Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization

Purpose To evaluate the prevalence of drug-drug interactions (DDI) in prescriptions of hospitalized patients and to identify risk factors associated. Methods A retrospective cross-sectional analysis of prescription data and medical records from a public hospital in Brazil was conducted to identify p...

Full description

Bibliographic Details
Main Authors: Cristiano Soares Moura, Francisco Assis Acurcio, Najara Oliveira Belo
Format: Article
Language:English
Published: Canadian Society for Pharmaceutical Sciences 2009-09-01
Series:Journal of Pharmacy & Pharmaceutical Sciences
Online Access:https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6266
id doaj-6dd4122a57664cf1bbe57024f3877a7e
record_format Article
spelling doaj-6dd4122a57664cf1bbe57024f3877a7e2020-11-25T04:01:58ZengCanadian Society for Pharmaceutical SciencesJournal of Pharmacy & Pharmaceutical Sciences1482-18262009-09-0112310.18433/J35C7ZDrug-Drug Interactions Associated with Length of Stay and Cost of HospitalizationCristiano Soares Moura0Francisco Assis Acurcio1Najara Oliveira Belo2Multidisciplinar Institute of Health, Federal University of BahiaSocial Pharmacy Department, Federal University of Minas GeraisMultidisciplinar Institute of Health, Federal University of BahiaPurpose To evaluate the prevalence of drug-drug interactions (DDI) in prescriptions of hospitalized patients and to identify risk factors associated. Methods A retrospective cross-sectional analysis of prescription data and medical records from a public hospital in Brazil was conducted to identify potential DDI. An inappropriate drug combination was identified and classified with a standard drug interaction source. The main diagnoses were classified with Charlson Comorbidity Index (CCI). Sex, age, polypharmacy and length of stay, among other variables, were correlated with the frequency of potential DDI. Results The study included 589 patients and 3,585 prescriptions. Thirty-seven percent of the patients were exposed to at least one potential interaction during their stay in the hospital. The most frequent interacting pair was Digoxin+Furosemide (11%). In univariate analysis, several variables were associated with DDI, including sex, age, number of prescribed drugs, length and cost of hospitalization and CCI. Multivariate analysis showed that the adjusted odds of being prescribed a potential DDI among patients in polypharmacy was almost five-fold that of patients taking less than five drugs. Further, length of stay, CCI and cost of hospitalization were independently associated with DDI. Conclusion Analysis of prescription data found that a substantial number of potential DDI were identified. Results of this study indicate that DDI is associated with number of prescribed drugs, increased duration of stay in the hospital and cost, which suggest that DDI are a significant clinical and economic problem. Potential damage to patients could be avoided.https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6266
collection DOAJ
language English
format Article
sources DOAJ
author Cristiano Soares Moura
Francisco Assis Acurcio
Najara Oliveira Belo
spellingShingle Cristiano Soares Moura
Francisco Assis Acurcio
Najara Oliveira Belo
Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
Journal of Pharmacy & Pharmaceutical Sciences
author_facet Cristiano Soares Moura
Francisco Assis Acurcio
Najara Oliveira Belo
author_sort Cristiano Soares Moura
title Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
title_short Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
title_full Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
title_fullStr Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
title_full_unstemmed Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
title_sort drug-drug interactions associated with length of stay and cost of hospitalization
publisher Canadian Society for Pharmaceutical Sciences
series Journal of Pharmacy & Pharmaceutical Sciences
issn 1482-1826
publishDate 2009-09-01
description Purpose To evaluate the prevalence of drug-drug interactions (DDI) in prescriptions of hospitalized patients and to identify risk factors associated. Methods A retrospective cross-sectional analysis of prescription data and medical records from a public hospital in Brazil was conducted to identify potential DDI. An inappropriate drug combination was identified and classified with a standard drug interaction source. The main diagnoses were classified with Charlson Comorbidity Index (CCI). Sex, age, polypharmacy and length of stay, among other variables, were correlated with the frequency of potential DDI. Results The study included 589 patients and 3,585 prescriptions. Thirty-seven percent of the patients were exposed to at least one potential interaction during their stay in the hospital. The most frequent interacting pair was Digoxin+Furosemide (11%). In univariate analysis, several variables were associated with DDI, including sex, age, number of prescribed drugs, length and cost of hospitalization and CCI. Multivariate analysis showed that the adjusted odds of being prescribed a potential DDI among patients in polypharmacy was almost five-fold that of patients taking less than five drugs. Further, length of stay, CCI and cost of hospitalization were independently associated with DDI. Conclusion Analysis of prescription data found that a substantial number of potential DDI were identified. Results of this study indicate that DDI is associated with number of prescribed drugs, increased duration of stay in the hospital and cost, which suggest that DDI are a significant clinical and economic problem. Potential damage to patients could be avoided.
url https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/6266
work_keys_str_mv AT cristianosoaresmoura drugdruginteractionsassociatedwithlengthofstayandcostofhospitalization
AT franciscoassisacurcio drugdruginteractionsassociatedwithlengthofstayandcostofhospitalization
AT najaraoliveirabelo drugdruginteractionsassociatedwithlengthofstayandcostofhospitalization
_version_ 1724445009643569152